This is in reply to the query received from BSE dated 18th August 2025 pertaining to resignation of Mr. Manoj Lodha as Chief Financial Officer of the Company w.e.f. 5th August 2025. Resignation Letter received from Mr. Manoj Lodha submitted herewith.
Announcement under Regulation 30 (LODR)-Change in Management
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Sudarshan Pharma Industries Ltd on 6ix
Earlier from Sudarshan Pharma Industries
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Sudarshan Pharma Industries Ltd Press Release Aug 12 2025
- Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
- Shareholder Meeting / Postal Ballot-Outcome of EGM
- Sudarshan Pharma Industries Ltd Press Release Aug 11 2025
Later from Sudarshan Pharma Industries
- Announcement under Regulation 30 (LODR)-Updates on Acquisition
- Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
- Sudarshan Pharma Industries Ltd Press Release Sep 08 2025
- Closure of Trading Window
- Sudarshan Pharma Industries Ltd Press Release Sep 30 2025
Follow Sudarshan Pharma Industries into a list and get an email when it puts out news.
Follow Sudarshan Pharma Industries